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INTRODUCTION 
Laparoscopic cholecystectomy is one of the most common general 
surgical procedures performed in the world. Most surgeons spend a significant 
time in perfecting the technique of laparoscopic cholecystectomy and offering 
better outcomes to their patients. Pain is an important aspect of patient concern 
in all surgeries. It has been proved by numerous studies that reducing pain in 
post-operative period can contribute to faster discharges and reduced 
hospitalization times. Reduced hospitalization times lead to reduced 
hospitalization costs. In India, with much of its population dependent on the 
public health care system for much of its surgical needs, reduced 
hospitalization times can have a dramatic impact on reducing the public health 
costs.  Reduced pain scores are also asscociated with better patient satisfaction 
outcomes. In this study I have aimed at reducing pain scores associated with 
diaphragmatic pain after Laparoscopic cholecystectomy using a simple 
technique of active gas aspiration.  
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AIMS & OBJECTIVES 
1. To evaluate the effect of active gas aspiration in patients undergoing 
Laparoscopic Cholecystectomy on  shoulder pain and upper abdominal 
pain 
 
2. To evaluate the effect of active gas aspiration in patients undergoing 
Laparoscopic Cholecystectomy on hospitalisation durations. 
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REVIEW OF LITERATURE 
Laparoscopy cholecystectomy has been considered the gold standard 
management for gallstone disease for the past 22 years and has superseded 
open cholecystectomy. (1) Laparoscopic management of gall stone disease 
through Laparoscopic Cholecystectomy has proved to be a means to faster 
recovery. Early return to activities of daily living is also facilitated by choosing 
the laparoscopic approach over the open approach. (2) Techniques in 
laparoscopic cholecystectomy have improved significantly over the years. 
Numerous surgeons have perfected the technique over the past few decades to 
evolve newer methods to improve the safety of Laparoscopic Cholecystectomy. 
The incidence of bile duct injuries all over the world have decreased 
tremendously and there is now greater awareness about the critical view of 
safety. It is thus essential to understand the history of laparoscopic 
cholecystectomy. 
 
HISTORY OF LAPAROSCOPIC CHOLECYSTECTOMY 
In 1882, Carl Langebuch (1846-1901) of Germany performed the first 
cholecystectomy. In 1985 (103 years later), Prof Dr Erich Mühe of Germany 
performed the first laparoscopic cholecystectomy (LC).He performed 94 such 
procedures before another surgeon, PhillipeMouret of Lyon, France, performed 
his first laparoscopic cholecystectomy in 1987, followed by Francois Dubois of 
Paris, France, in 1988 (3) 
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Prof Dr Med Erich Mühe of Böblingen, Germany, performed the first 
laparoscopic cholecystectomy on September 12, 1985. The German Surgical 
Society rejected Mühe in 1986 after he reported that he had performed the first 
laparoscopic cholecystectomy, yet in 1992 he received their highest award, the 
German Surgical Society Anniversary Award. 
In 1990 in Atlanta, at the Society of American Gastrointestinal Surgeons 
(SAGES) Convention, leading surgeons like Perissat, Berci, Cuschieri, Dubois, 
and Mouret were recognized by SAGES for being the pioneers in  laparoscopic 
cholecystectomies. Dr Eric Muhe, sadly, was not given any recognition. His 
inability to publish in English cost him dearly. An attempt at publishing in 
American Journal of Surgery at the insistence of the French master Dubois also 
failed due to poor English. 1999 was a momentous year. Prof Muhe was 
recognized by SAGES for having performed the first laparoscopic 
cholecystectomy. SAGES invited Mühe to present the Storz Lecture. Mühe's 
presentation, titled “The First Laparoscopic Cholecystectomy,” in March 1999 
in San Antonio, Texas was well received in front of 1000 surgeons from around 
41 countries. Finally, Mühe had received the worldwide acclaim that he 
deserved for his pioneering work.(3) 
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Eric Muhe, surgeon par excellence and champion cyclist 
History of laparoscopy is though much older. In 1901, Georg 
Kelling of Dresden, Germany,(4) performed the first laparoscopic procedure in 
dogs, and, in 1910, Hans Christian Jacobaeus of Sweden performed the first 
laparoscopic operation in humans. (5) The first publication on modern 
diagnostic laparoscopy by Raoul Palmer appeared in 1947, followed by the 
publication of Hans Frangenheim and Kurt Semm. Hans Lindermann and Kurt 
Semm practised CO2 hysteroscopy during the mid-1970s. In 1981, Semm, from 
the gynecological clinic of Kiel University, Germany, performed the first 
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laparoscopic appendectomy. Following his lecture on laparoscopic 
appendectomy, the president of the German Surgical Society wrote to the 
Board of Directors of the German Gynecological Society suggesting 
suspension of Semm from medical practice. Subsequently, Semm submitted a 
paper on laparoscopic appendectomy to the American Journal of Obstetrics 
and Gynecology, which was at first rejected as unacceptable for publication on 
the grounds that the technique reported on was "unethical," but finally 
published in the journal Endoscopy. (6) Richard Zollikofer, a Swiss 
gynecologist, was one of the first to recognize the benefits of using carbon 
dioxide to create pneumoperitoneum and introduced his method for doing so in 
1924; (other sources cite the date as 1920). This procedure could be performed 
in place of filtered air or oxygen because of its fast absorption and to minimize 
the risk of explosion. Later, JC Rubin in 1925 also used CO2 gas to distend the 
uterine cavity.  
One of the most major events in laparoscopy was the introduction of 
Veress needle. The Veress needle was an accidental discovery. The tool was 
first developed in 1932 by Janos Veres, a Hungarian internist working 
with tuberculosis patients. At the time, one of the mainstays of treatment was to 
collapse an infected lung and allow lesions to heal. (7) The needle was 
introduced as a safer technique to give patients such pneumothoraces. It was 
not until 1938, when he published his invention in the Germanliterature, that 
the needle became more broadly known outside of Hungary. (8)Raoul 
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Palmer introduced the use of the Veress needle in laparoscopy to establish 
a pneumoperitoneum. 
 
Veress needle (9) 
Laparoscopy is basically visualisation of the peritoneal cavity using an 
endoscope. The entire process is assisted by a pneumoperitoneum that distends 
and separates the abdominal wall from its contents.  Adequate visual clarity, 
space to perform diagnostic, therapeutic procedures and maneuvers and 
maintenance of a normal physiologic state is required for safe surgery.  To 
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achieve this, the abdpminal cavity is inflated with a gas. This is known as 
pneumoperitoneum. 
There are a number of factors that determine the appropriateness of the 
gas being used for creation of pneumoperitoneum.  
• type of anaesthesia 
• physiologic compatibility 
• toxicity 
• ease of use 
• safety 
• delivery method 
• cost 
• non-combustibility.  
Gases used for pneumoperitoneum include: 
• carbon dioxide (CO2) 
• air 
• oxygen 
• nitrous oxide (N2O) 
• argon 
• helium  
• mixtures of these gases 
 
CO2 gas insufflation is preferred by most laparoscopic surgeons because 
it has a high diffusion coefficient and is a normal metabolic end product rapidly 
cleared from the body.
also not combustible.
cardiac arrhythmias are also known to occur with CO2 pneumoperitoneum.
Due to the risk of CO2 induced hypercarbia, N2O is  prefe
patients with cardiac disease. In prolonged procedures, CO2 retention is 
possible and is reflected by tachycardia and acidosis.
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 CO2 is also highly soluble in blood and tissues. It is 
  The gas embolism risk is lowest when using CO2.
 
 But 
(10)
  
rred in certain 
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Pneumoperitoneum is usually introduced  by the use of a needle like 
Veress needle  or trocar device to traverse the abdominal wall and distend the 
peritoneal cavity.   A safer method of access is using an open incision and 
entering by direct vision through the peritoneum. This is popularly known as 
the Hasan’s method. An extreme degree of caution is required with any method 
of pneumoperitoneum.  Abdominal penetration complications and incorrect gas 
placement may result in bleeding or gas dissection within the abdominal 
wall. There is also the risk of  bowel injury, puncture of intra-abdominal 
vessels, dissection of the fascia and omental injuries.(13) 
 
Risk of aortic injury during trocar entry 
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After peritoneal access, a gas delivery system is used to inflate and 
maintain the abdominal distention.  Preset pressures of 15 mm Hg or less are 
safest to maintain pneumoperitoneum and allow performance of laparoscopic 
techniques.  Intra-abdominal pressures in excess of 25 mm Hg are associated 
with increased airway pressure, increased intrathoracic pressure, increased 
femoral venous pressure and signs of cardiovascular stimulation with 
tachycardia and hypertension. (11) Large patients and those who have had 
multiple abdominal surgeries present a challenge to establish a 
pneumoperitoneum. Patient selection for laparoscopic procedures and surgical 
judgement concerning the appropriateness of laparoscopic versus open surgery 
should be individualized for each circumstance.(13) 
Gas delivery systems are composed of a containment cylinder, 
insufflator (gas throttling down pressure regulating unit), tubing, filter and 
abdominal entry device or port.  The gases used for medical purposes have 
their production regulated by the Food and Drug Administration. 
Gas cylinders are made of a ferrous alloy that meets the specifications of 
the Department of Transportation thus ensuring safe transport.  The cylinders 
contain the gas as a liquid under pressure (57 atmospheres).  Over time, the 
cylinders build up inorganic and organic contamination.  This occurrence 
requires filtration of the gas prior to insufflation of a patient’s abdomen. (12) 
The pressure change from the containment cylinder to insufflator and into the 
patient’s abdomen causes cooling by the Jewel-Thompson effect.(14) 
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The temperature of carbon dioxide gas is about 20.1° C as it enters the 
abdomen.  The cool gas causes hypothermia if the gas is not pre-
conditioned.(15)  Gas flow also contributes to hypothermia by convection 
effects.  There is enhanced evaporation from the bowel surface due to gas 
turbulence from pressurized delivery.  Additionally, general anesthesia causes 
patients to be unable to maintain thermal stability.  The net effect is a loss of 
0.3 degree C per 60 liters of gas insufflated. In addition, hypothermia may 
cause decreased gastrointestinal motility and lead to increased potential for 
ileus.(16) 
When the laparoscope is first introduced into the abdominal cavity lens, 
fogging often occurs.  This phenomenon is due to the relatively cold dry lens 
being introduced into a warm moist environment causing the dew point to be 
reached.  This results in condensation forming on the internal lens surface.  
When the insufflation gas is heated and hydrated or a surface wetting agent is 
used, no lens fogging occurs and the visual field is clear. (13) 
The gases used for pneumoperitoneum have low water content.  CO2 
has less than 200 parts per million of water.  Dry insufflation gases cause 
drying of the peritoneum and result in intact mesothelial cells being lost or 
desiccated from the peritoneum surface.  To preserve peritoneal surface 
integrity and decrease the tendency of formationof adhesions  continuous or 
intermittent moistening should be performed. (13) 
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All mechanical systems have inherent weaknesses.  Insufflators require 
proper calibration and maintenance.  Insufflator pressure accuracy depends on 
the quality of the gauges used in the insufflator.  Wide ranges of variation are 
seen due to gauge inaccuracy.(17)  Pressure testing should be done regularly to 
assure proper readings. 
Over time, insufflators become contaminated on their internal and 
external surfaces.  Germicidal cleaning of external ports is important.  Gas 
filtration to 0.3 microns prior to abdominal entry assures reduction of 
quantitative exposure of the peritoneal cavity to these organic and inorganic 
materials. (13) 
Initial abdominal entry pressure readings should be low—less than 2-3 
mm Hg.  Elevated initial pressures indicate improper placement.  Increased 
intra-abdominal pressures after proper access can impede venous return and 
result in potential anaesthesia complications.  Pressure on intra-abdominal 
surfaces due to the pneumoperitoneum can inhibit bleeding giving a false sense 
of security regarding hemostasis.  Prior to concluding any procedure, surgical 
sites need to be observed with reduced pressure to assure appropriate 
hemostasis. (13) 
During laparoscopic procedures the abdominal cavity can become 
contaminated with smoke from the lasers or the electrosurgical device used.  
On a toxicologic basis, tissue combustion within the closed abdomen at 
laparoscopy is an iatrogenic smoke poisoning incident.  Toxic chemicals 
produced by pyrolysis of human tissue are listed in this table 
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These chemicals affect peritoneal cells and other cellular components 
(i.e. activation of macrophages and increased production of tumor necrosis 
factor).  Absorption of these chemicals occurs via the peritoneum.  Combustion 
processes that occur in low oxygen environments cause elevated CO emissions 
and are common in the laparoscopic situation.  Peritoneal absorption of CO 
causes carboxyhemoglobin formation. Carbon monoxide has 200-240 times 
greater affinity for hemoglobin than oxygen.  The half-life of CO is 5.33 hours 
in room air.  Depending on the amount of smoke produced, anaesthetic oxygen 
concentration and whether smoke evacuation was performed during the 
procedure, determines the postoperative effects of CO and the time that would 
be required to return to preoperative levels.(18)  Carbon monoxide (CO) is 
known to cause cardiac arrhythmias and can initiate or exacerbate many intra- 
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and postoperative complications.  For these reasons smoke within the 
pneumoperitoneum should be continuously or intermittently evacuated.(13) 
Methemoglobinemia may occur during laparoscopic procedures when 
abdominal tissue combustion occurs.  Methemoglobin is the oxidative product 
of hemoglobin causing the reduced ferrous (Fe2+) to be converted to the ferric 
(Fe3+) form.  The difference between methemoglobin and oxyhemoglobin in 
the ferric state is that methemoglobin is formed from unoxygenatedhemoglobin 
and is not capable of carrying oxygen or carbon dioxide.  This property shifts 
the oxyhemoglobin dissociation curve to the left, inhibiting oxygen delivery to 
tissues, and may lead to anoxia.  The eventual concentrations of smoke and 
subsequent physiologic changes that occur depend on the amount of tissue 
pyrolized, duration of smoke exposure and effectiveness of smoke evacuation.  
It must be noted that pulse oximetry does not give a proper evaluation of 
oxygen saturation in the presence of dyshemoglobinemias (carboxyhemoglobin 
and methemoglobinemia). (19) 
Peritoneal defenses are also effected by irrigation and suction.  Irrigation 
serves to separate tissue surfaces and remove debris and clotted material.  
However, irrigation also causes dilution washout of resident peritoneal 
macrophages.  Macrophages direct host defense mechanisms that result in 
recognition, phagocytosis and destruction of foreign substances. 
As a result of irrigating the peritoneal cavity with 1 liter of fluid,  
60-80% of the original number of macrophages are washed out.  It has been 
shown in the murine model and in patients undergoing peritoneal dialysis that 
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restoration of 90% of the original complement of macrophages requires 72-84 
hours. (20) 
Postoperatively, macrophages are intimately involved in protecting the 
peritoneum and abdominal cavity from foreign material, bacteria and foreign 
bodies.  They are also involved with the initiation of reperitonealization. 
Tissue combustion generates 284 mg of particulates from each gram of 
tissue pyrolized or 0.3-3.0 x 109 particles per gram of tissue vaporized.  These 
particles range from 0.1-1.0 microns in size clustering between 0.2-0.5 
microns.  This material is phagocytosed by macrophages, chemically digested, 
and causes macrophage activation, alteration in chemotaxis and increased 
cytokine production. 
The seemingly inactive invisible pneumoperitoneum is not a static 
condition and must not be ignored in laparoscopic surgery.   
The pneumoperitoneum is a dynamic space that affects the patient’s general 
well being, and specific physiologic cellular processes.  The insufflation gas 
needs to be filtered to reduce contamination, heated to reduce hypothermia and 
hydrated to preserve cellular integrity and reduce adhesion formation.  It is 
important to recognize the effects of intra-abdominal therapy and the 
consequences of surgical devices.  This includes tissue particles, aerosol 
production, the by-products of combustion, and their effect on peritoneal 
tissues locally and on the body chemistry and metabolism as a whole. (13) 
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THE PROBLEM OF SHOULDER PAIN AFTER LAPAROSCOPY 
Pain in the early postoperative period is one of the most common  
complaints in the post-cholecystectomy patient. It is one of the major reasons 
which contribute to delayed recovery.  (21) Although pain after laparoscopic 
surgery is less severe and of shorter duration compared with open surgery, 
shoulder pain (SP), which is absent after conventional laparotomy, is a source 
of considerable postoperative discomfort following laparoscopy. (22) A meta-
analysis was done by Donatsky et al on the various strategies to reduce 
shoulder pain after laparoscopic cholecystectomy. (22) 
The origin of referred pain to the shoulder after laparoscopy is only 
partly understood. The tissue trauma theory is based on the stretching of the 
peritoneum and diaphragm secondary to pneumoperitoneum. (23) The stretching 
effect on muscle fibers of the diaphragm due to insufflation results in tearing of 
blood vessels, traction on nerves, and release of inflammatory mediators that 
elicits referred pain to the shoulder. (24) 
CO2 gas is normally absorbed from the peritoneal cavity during the first 
2–3 postoperative days, but can persist for up to 1 week. (25) (26) It has been 
shown that there is significant correlation between CO2 bubble volume under 
the right hemidiaphragm and postoperative pain. (27) The last theory for referred 
shoulder pain is the irritative effect of CO2 gas. This theory is based on the 
assumption that CO2 gas is converted to carbonic acid on the moist surface of 
the peritoneum. This irritates the peritoneum and diaphragm leading to referred 
pain to the shoulder.(24) 
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TO DRAIN or NOT TO DRAIN  
The Donatsky Meta-analysis also talks about the question of drains. The 
use of drains to minimize SP is based on the assumption that it can help to 
evacuate the peritoneal cavity from residual CO2. This prevents both pockets 
of gas limiting the suction support on organs and the irritative effect of CO2. 
When looking at the larger RCTs (28) (29) (30) separately the use of closed drains 
is not associated with a reduction of SP. On the contrary, the association is the 
opposite with an increase in SP when looking at the result from the meta-
analysis. (22) Two large RCTs that evaluated the effect of drainage on  overall 
pain after LC found a significant increase in pain sensation (31)(32) 
 
Abdominal Drain kit can be used as drains post-cholecystectomy 
27 
 
 In searching for effective ways to reduce postoperative pain, the risks 
related to the intervention must be considered. The use of drains has been 
shown to increase the rates of intra-abdominal and wound infections, decrease 
the pulmonary function, and prolong hospital stay. (32) 
The use of active gas aspiration to evacuate residual CO2, which one 
study found significantly reduced severity of SP (33), could be used without the 
risks associated with drains. (22) We will be discussing more about active gas 
aspiration in this review. 
 
Incidence or severity of shoulder pain associated with drainage (22) 
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ABDOMINAL WALL LIFT 
With the AWL technique, it is possible to perform gasless laparoscopic 
surgery, thus completely eliminating the irritative effect, loss of suction 
support, as well as minimizing the trauma to the diaphragmatic muscle fibers. 
When comparing AWL to high-pressure pneumoperitoneum (C12 mmHg), the 
results are either nonsignificant(34) or correlated to a reduction in the incidence 
of SP Compared with low-pressure pneumoperitoneum (B8 mmHg), AWL is 
associated with a significant increase in incidence of SP (34)—an increase that 
also was found in a meta-analysis. (35)  
 
The subcutaneous abdominal wall lift method for gasless laparoscopic-assisted 
adnexal surgery with a wound retractor. The abdominal wall was lifted by a 
handle attached to a subcutaneous surgical wire and L-shaped bar that was 
fixed to a table above the right shoulder of the patient.(37) 
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The AWL technique thus is related to a higher incidence in SP 
compared with the low-pressure pneumoperitoneum. Although AWL only has 
an effect on SP compared with high-pressure pneumoperitoneum, it eliminates 
the pathophysiological effects of pneumoperitoneum. Compared with 
laparoscopy with pneumoperitoneum, the AWL technique is an obsolete 
technique and has only clinical relevance for select patients, for example in the 
elderly and in patients withcardiovascular or renal disorders (36) where the 
negative effect on cardiac function related to increased intraabdominal pressure 
from pneumoperitoneum is undesired.(22) 
 
Incidence of severity of shoulder pain associated with abdominal wall lift 
(22) 
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LOW PRESSURE PNEUMOPERITONEUM 
With low-pressure pneumoperitoneum, it is possible to minimize the 
trauma on the peritoneum and diaphragmatic muscle fibers by limiting the 
intra-abdominal pressure. Low-pressure (B10 mmHg) has, in several studies, 
been associated with a significant reduction in both incidence and severity of 
SP (22), indicating that minimizing the trauma correlates to a reduction in 
referred pain. The pressures used in the intervention and control arms vary 
greatly between RCTs. This heterogeneity makes comparison difficult. Only 
one study identified, evaluated the effect of CO2 insufflation rate and found 
that a low flow rate of 2.5 L/min reduced the incidence of SP. (38) This 
significant reduction was found even though the pressure limit during surgery 
was kept at 12–15 mmHg, indicating that the rate with which the fibers are 
stretched is a contributing factor in the etiology of SP. Even though low 
pressure can reduce SP, there are adverse physiological effects to be considered 
when applying pneumoperitoneum. These effects can be divided into those 
related to increased abdominal pressure and those related to CO2 gas 
absorption (39) and are mainly associated with high pressure affecting liver, 
kidney, and respiratory function. (23) 
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Laparoscopic tower with an insufflator. Pressure monitoring can be 
done 
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These side effects should not be a problem for a low-pressure setting in 
otherwise healthy patients . A study has shown that abdominal laparoscopic 
surgeryis associated with a restrictive respiratory pattern and significantly 
reduced pulmonary function that is independent of anaesthesia. (40) 
 
Furthermore, patients who developed referred diaphragmatic pain to the 
shoulder had a significantly greater reduction in their pulmonary function 
compared with patients without SP. The study thus concludes that 
diaphragmatic dysfunction rather than gallbladder area stimulation plays a role 
in both the development of SP and respiratory dysfunction after LC. As for the 
irritative effect of CO2 on the peritoneal surface, one small study compared 
CO2 to N2O and found no difference in the incidence of SP. (41) The use of 
other gasses for pneumoperitoneum is an area that requires further research. (22) 
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Incidence and severity of shoulder pain associated with low-pressure 
pneumoperitoneum(22) 
 
 
The review by Donatsky et al ( 22) has not taken into account the possible 
role of operation duration in the development of postoperative shoulder pain. 
Only a few of the included articles mention the relevance of operation duration 
on pain development, and none have accounted for it in their data analysis.  
It has been shown that prolonged duration ( >45 min) results in significantly 
more intense shoulder pain during the first 3 postoperative days.( 24) 
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POSITIONING  
In one very small study conducted in Japan, it was speculated that 
patients with flexed arms had lower incidence of shoulder pain when compared 
to patients with abducted arms. However, the study was performed not in LC 
patients but in gynaecological surgeries. (42) 
 
 
Arm at 90 degrees abduction 
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BUPIVACAINE SPRAY 
Irrigation of the surgical bed with 20 cc of Bupivacaine in 0.5% normal 
saline in patients undergoing LC showed significant reduction in early post-
operative pain scores. However this study did not evaluate shoulder and 
abdominal pain separately. The analgesic dose requirement, however, didn’t 
show much difference. (43) These findings were validated by one more Indian 
study. (44) 
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ACTIVE GAS ASPIRATION 
A small number of studies performed all over the world have 
experimented on active gas aspiration as a means of relieving the 
diagphramatic stretch pain due to retained gas. As discussed earlier there are a 
huge number of factors that contribute to the shoulder pain seen in post 
cholecystectomy patients. The pioneering study by Jackson et al (27) in 1996 
was among the earliest to predict that the shoulder pain is directly related the 
amount of CO2 gas retained in the immediate post-operative period. The 
Donatsky review gave us a comprehensive analysis of the factors that cause 
shoulder pain due to CO2 gas. The study mentioned the various theories which 
could cause pain as discussed earlier. (22) 
 
The tissue trauma theory is based on the stretching of the peritoneum 
and diaphragm secondary to pneumoperitoneum. (23) The stretching effect on 
musclefibers of the diaphragm due to insufflation results in tearing of blood 
vessels, traction on nerves, and release of inflammatory mediators that elicits 
referred pain to the shoulder. (24) 
 
CO2 gas is normally absorbed from the peritoneal cavity during the first 
2–3 postoperative days, but can persist for up to 1 week. (25) (26) It has been 
shown that there is significant correlation between CO2 bubble volume under 
the right hemidiaphragm and postoperative pain. (27) The last theory for referred 
shoulder pain is the irritative effect of CO2 gas. This theory is based on the 
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assumption that CO2 gas is converted to carbonic acid on the moist surface of 
the peritoneum. This irritates the peritoneum and diaphragm leading to referred 
pain to the shoulder. (24) 
 
One of the earliest studies to discuss the possibility of active gas aspiration 
was by Atak et al from Turkey in 2011. (33)This pioneering study also 
investigated the various theories that can cause diaphragmatic pain and 
summarized them succinctly. The study said that it is multifactorial in origin 
and listed the following causes as possible factors.(38)(45)(46) 
 
• The duration of pneumoperitoneum, 
• The rate of gas insufflations. 
• The peak intraperitoneal pressure, 
• The temperature of gas 
 
Temperature of the gas did not seem to have much a role as indicated by 
this randomized control study which said that gas warming does not reduce, 
and probably increases, postoperative shoulder tip and subcostal pains. (46) The 
Donstasky review has already mentioned that lower duration of surgery and 
low pressure surgery can lead to reduced shoulder pain.(22) 
 
 
Endoscopic suction cannula 
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The findings of the Atak study (33) were quite remarkable. I have 
summarized them here.  
 
Among a total of 104 patients (24 male, 80 female), the mean age was 
46.87 +/-10.9 years. There was no statistically significant difference between 
the groups in terms of mean age, operation time, and insufflated CO2 volume. 
The required analgesic doses were significantly lower in the aspirated patient 
group (351.8 +/- 43.05mg vs. 370.4 +/- 43.06 mg). The pain scores for shoulder 
(3.26 +/- 2.37 vs.5.46 +/- 2.39) and abdominal pain (3.26 +/- 2.06 vs. 6.26 +/- 
2.0) were significantly lower in the patients (P<0.01 ). The mean hospital stay 
was 2.20 +/- 0.76 d in the aspirated group versus 2.43 +/- 0.65 in the control 
group andthere were no statistically significant differences between the 2 
groups. 
 
Another significant study in Thailand by Tuvayanon et al (2018)(48) was 
also a Randomised control study comparing the effects of usual gas release, 
active aspiration, and passive-valve release on abdominal distension in patients 
who have undergone laparoscopic cholecystectomy. This landmark study from 
our perspective had significant findings. The active aspiration group had 
significantly reduced postoperative abdominal distensions at 30 min, 4and 24 
hours compared with the control group (50.0% vs 80.9%, 43.8% vs 76.6%, 
33.3% vs 57.4%, respectively; P < 0.05). Similarly, the passive-valve release 
group had significantly reduced postoperative abdominal distensions at 4 and 
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24 hours compared with the control group (51.1% vs 76.6%, 57.4% vs 36.2%; 
P < 0.05).  
 
Both intervention groups had significantly reduced postoperative 
shoulder pain at 4 and 24 hours compared with the control group (P < 0.001). 
In addition, the postoperative ambulation times for the active aspiration group 
were significantly shorter than those for the control and passive-valve release 
groups (P < 0.001). 
 
Another Thai study by Leelasuwattanakul et al (49) was also a 
randomised control study that aimed at evaluating the effectiveness of active 
gas aspiration to reduce postoperative shoulder pain in infertile women 
undergoing day-case diagnostic laparoscopy. The study concluded that active 
gas aspiration provided a significantly superior effect on postoperative shoulder 
pain relief after diagnostic laparoscopy when compared to simple gas 
evacuation, without any adverse events. 
 
Therefore various literature sources have concluded that CO2 gas is a 
possible cause of diaphragmatic irritation and shoulder pain. Therefore, release 
of gas could prove to be a major step in reducing the morbidity due to shoulder 
pain. 
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MATERIALS & METHODS 
Study Centre 
Institute of General Surgery, Madras Medical College and Rajiv Gandhi 
Government General Hospital, Chennai 
 
Duration of Study 
1st October 2017 to 1st September 2018 
Study Design 
Randomised Control Study  
Single Blinding ( Patient) 
 
Sample Size 
50 in each group {n = Z2 1-α/2 P(1-P) /e2 P=3% e= 5% Z=1.96} 
 
Between 1st October 2017 and 1st September 2018, 100 patients 
diagnosed with cholelithiasis who underwent elective Laparoscopic 
Cholecystectomy procedures were enrolled in this prospective randomized 
controlled trial. The study was conducted at Rajiv Gandhi Govt General 
Hospital and Madras Medical College, Chennai, India in the Institute of 
General Surgery. 
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Diagnosis of cholelithiasis was made using ultrasound abdomen (USG) 
and CT scanning. 
 
The patients was assessed by the anaesthesiology department using the 
American Society of Anesthesiologists (ASA) classification and all patients 
were given an ASA score of 1 or 2. 
 
INCLUSION CRITERIA: 
• All patients undergoing Laparoscopic Cholecystectomy for 
cholelithiasis between 20 to 85 years. 
 
EXCLUSION CRITERIA 
• ASA physical statusof  3 and 4, 
• Pregnancy 
• History of Drug /alcohol abuse 
• Patients on chronic painkiller support 
• Active cholecystitis 
• Malignancy 
• Severe pre-operative pain 
• Abnormal liver function tests 
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• Severe gastritis 
• <20 years and > 85 years 
• Conversion from Laparoscopic to Open surgery 
• Surgeries in which drains were used 
The age, sex, operating time and the hospitalisation duration times were 
noted. Upper abdominal pain was recorded at 8 hours. Shoulder pain was 
recorded at 8, 12 and 24 hours. Visual Analogue scale was used for recording 
pain scores.  
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ANAESTHESIA 
 
The same general anaesthesia technique was followed for all patients.  
• They were premedicated with Inj. Glycopyrollate 0.2 mg IV and Inj. 
Midazolam 0.02 mg/kg half an hour before induction.  
• General anaesthesia was induced with inj. Fentanyl 1-2 mcg/kg and Inj. 
Thiopentone 2-5 mg/kg in titrated doses. 
• Orotracheal intubation was facilitated with inj. Atracurium 0.5-0.6 
mg/kg. 
• Anaesthesia was maintained with oxygen in nitrous oxide (1:1) and 
sevoflurane 1-2%.  
• Minute ventilation was adjusted to keep the end tidal CO2 at 35-45 
mmHg 
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RANDOMISATION and PROCEDURE 
Patients were divided into 2 groups, group Test/I (n=50) and group 
Control/II (n=50) randomly and with appropriate consent and information. 
 
All patients underwent a standard LC with the North American four-port 
technique. The intra-abdominal gas pressure was set at a level of 12mm Hg and 
monitored during the operation.  
 
 
Patients in the active aspiration group (group I)  
Aspiration cannula was placed in the most lateral accessory port and 
oriented to the sub-diaphragmatic space. After the placement of the cannula, 
gas was released from the abdomen by opening the gas taps in rest of the ports 
for a period of 5 minutes and the recorded pressure reached 0 mm Hg After that 
, active aspiration was done for a period of 5 minutes to remove as much air as 
possible. This was done under vision with camera in position. The fascia at the 
umbilical/supra/sub umbilical port incision was closed at the end of the 
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operation with No 1 polypropylene or PDS. No intra-abdominal drain was 
placed in any patients. 
 
Sub Diaphragmatic space 
 
  
46 
 
 
 
 
 
Patients in the control group (group II)  
In the control group (group II), gas evacuation was performed using the 
port site by opening the gas taps only. The gas taps were kept open for a period 
of 5 min and the  recorded pressure reached 0 mm Hg before the camera port 
was removed.  
 
The fascia at the umbilical/supra/sub umbilical port incision was closed 
at the end of the operation with No 1 polypropylene or PDS. No intra-
abdominal drain was placed in any patients. 
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RECORDING PAIN SCORES 
Patients in both groups were unaware which group they had been 
allotted to. They were given analgesics Inj Tramadol 2cc ( 100mg ) Intra 
muscularly at 8 hrs, 12 hrs,  18 hrs and 24hrs postoperatively.  After 24 hrs 
they were prescribed Tab.Paracetamol + Tramadol twice a day. 
Upper abdominal pain was recorded at 8 hours. Shoulder pain was 
recorded at 8 , 12 and 24 hours. Visual Analogue scale was used for recording 
pain scores. The pain scores were always recorded prior to the immediate next 
analgesic dose.  
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STATISTICAL ANALYSIS 
The collected data were analysed with IBM.SPSS statistics software 
23.0 Version. To describe about the data descriptive statistics frequency 
analysis, percentage analysis were used for categorical variables and the mean 
& S.D were used for continuous variables. To find the significant difference 
between the bivariate samples in Independent groups the Unpaired sample t-
test and the Mann-Whitney U test was used. To find the significance in 
categorical data Chi-Square test was used similarly if the expected cell 
frequency is less than 5 in 2×2 tables then the Fisher's Exact was used. In all 
the above statistical tools the probability value .05 is considered as significant 
level.  
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RESULTS 
Group Statistics 
Groups N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Age 
Test 50 54 16.885 2.388 
Control 50 54 16.406 2.320 
Operating time 
in minutes 
Test 50 85 43.258 6.118 
Control 50 87 45.793 6.476 
  
50 
 
 
 
 
 
 
 
 
Independent Samples Test 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig.  
(2-tailed) 
Mean 
Differ
ence 
Std. 
Error 
Differ
ence 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Age 
Equal 
variances 
assumed 
.039 .844 -.042 98 .967 
-
.14
0 
3.329 -6.747 6.467 
Equal 
variances 
not 
assumed 
  
-.042 
97.
91
9 
.967 
-
.14
0 
3.329 -6.747 6.467 
Operati
ng time 
in 
minutes 
Equal 
variances 
assumed 
.295 .589 -.211 98 .833 
-
1.8
80 
8.909 
-
19.559 
15.799 
Equal 
variances 
not 
assumed 
  
-.211 
97.
68
4 
.833 
-
1.8
80 
8.909 
-
19.560 
15.800 
  
0
10
20
30
40
50
60
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54 54
Test Control
Age
 
  
 
The mean age in Group I  and Group II was 54 years with p value > 
0.05. 
The mean operating 
II is 87 min with p value > 0.05
 
60
65
70
75
80
85
Operating time in minutes
 
Age in years 
Operating Time 
in min 
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time in minutes in Group I is 85 min and in Group 
 
 
85
87
Test Control
Group I Test Group II Control 
54 +/- 16.885 54 +/- 16.406 
85 +/- 43.258 87 +/- 45.793 
 
P value 
0.967 
0.833 
  
The test and control patients were matched in age and operating times
 
Males 
Females 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
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Group I Test Group II Control
25 
25 
 
Test Control
Gender
Female Male
 
 
25 
25 
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Crosstab 
Groups 
Total Test Control 
Sex f Count 25 25 50 
% within Groups 50.0% 50.0% 50.0% 
m Count 25 25 50 
% within Groups 50.0% 50.0% 50.0% 
Total Count 50 50 100 
% within Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 
Value df 
Asymp. 
Sig.  
(2-sided) 
Exact 
Sig.  
(2-sided) 
Exact 
Sig.  
(1-sided) 
Pearson Chi-
Square 
.000a 1 1.000 
  
Continuity 
Correctionb 
0.000 1 1.000 
  
Likelihood 
Ratio 
0.000 1 1.000 
  
Fisher's Exact 
Test    
1.000 .579 
N of Valid 
Cases 
100 
    
  
There were an equal number of males and females in both arms of 
the study. P value =1 
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UPPER ABDOMEN PAIN, SHOULDER PAIN and 
HOSPITAL STAY 
Mann-Whitney Test 
Ranks 
Groups N Mean Rank 
Sum of 
Ranks 
Upper abdomen 
Pain 
Test 50 47.24 2362.00 
Control 50 53.76 2688.00 
Total 100 
  
8 hr Shoulder 
Test 50 39.45 1972.50 
Control 50 61.55 3077.50 
Total 100 
  
12 hrs shoulder 
Test 50 41.35 2067.50 
Control 50 59.65 2982.50 
Total 100 
  
24 hrs shoulder 
Test 50 40.42 2021.00 
Control 50 60.58 3029.00 
Total 100 
  
Hospitalisation 
duration in days 
Test 50 45.28 2264.00 
Control 50 55.72 2786.00 
Total 100 
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Group Statistics 
Groups N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
Upper abdomen 
Pain 
Test 50 1.20 .756 .107 
Control 50 1.40 .904 .128 
8 hr Shoulder 
Test 50 1.02 1.237 .175 
Control 50 3.08 2.602 .368 
12 hrs shoulder 
Test 50 .92 1.307 .185 
Control 50 2.56 2.426 .343 
24 hrs shoulder 
Test 50 .44 .812 .115 
Control 50 1.38 1.369 .194 
Hospitalisation 
duration in days 
Test 50 1.72 .970 .137 
Control 50 2.20 1.229 .174 
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Test Statisticsa 
 
Mann-Whitney U Z 
Asymp. Sig. 
(2-tailed) 
Upper abdomen Pain 1087.000 -1.213 .225 
8 hr Shoulder 697.500 -3.916 .0005 
12 hrs shoulder 792.500 -3.294 .001 
24 hrs shoulder 746.000 -3.827 .0005 
Hospitalisation 
duration in days 
989.000 -1.927 .054 
 
  
  
SHOULDER 
 
The upper abdomen pain score at 8 hours in the test group was 1.2 +/
0.756 and the upper abdomen pain score at 8 
+/- 0.904. The p value = 0.225 (>0.05) . Hence the variation in abdomen pain 
scores are not significant
0.00
0.50
1.00
1.50
2.00
59 
 
a. Grouping Variable: Groups 
PAIN 
8 hrs 12 hrs 24 hrs 
Test 1.02 .92 .44 
Control 3.08 2.56 1.38 
P value 0.0005 0.001 0.0005 
hrs in the control group was 1.4 
 
1.20
1.40
Test Control
Upper abdomen Pain 
 
- 
The shoulder pain score at 8 hours in the test group was 1.02 +/
and the shoulder pain score at 8 hrs in the c
The p value = 0.0005 (<0.05) . Hence the variation in shoulder pain scores at 8 
hrs is significant. The pain is more in the control group
The shoulder pain score at 12 hours in the test group was 0.92 +/
and the shoulder pain score at 12
The p value = 0.001 (<0.05) . Hence the variation in shoulder pain scores at 12 
hrs is significant. The pain is more in the control group
The shoulder pain score at 24 hours in the test grou
and the shoulder pain score at 24
The p value = 0.0005 (<0.05) . Hence the variation in shoulder pain scores at 
24 hrs is significant. The pain is more in the control group.
1.02
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
8 hrs
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ontrol group was 3.08 +/
 
hrs in the control group was 2.56 +/
 
p was 0.44 +/
hrs in the control group was 1.38 +/
 
.92
.44
3.08
2.56
12 hrs
Shoulder pain
Test Control
 
- 1.237 
- 2.602. 
- 1.307 
- 2.426. 
- 0.812 
- 1.369. 
1.38
24 hrs
The mean hospitalisation duration in Group I Test was 1.72 +/
0.970 days. The mean hospitalisation duration in Group II Control was 
2.20 +/- 1.229 days. The p value = 0.054 (>0.05).  The difference is 
hospitalisation duration between the 2 groups is not significan
 
0.00
0.50
1.00
1.50
2.00
2.50
Hospitalisation duration in days
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1.72
2.20
Test Control
 
- 
t. 
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STATISTICS IN PATIENTS WITH OPERATING TIME 
>120 min 
Mann-Whitney Test 
Ranksa 
Groups N 
Mean 
Rank 
Sum of 
Ranks 
Upper abdomen 
Pain 
Test 14 13.07 183.00 
Control 16 17.63 282.00 
Total 30 
  
8 hr Shoulder 
Test 14 7.57 106.00 
Control 16 22.44 359.00 
Total 30 
  
12 hrs shoulder 
Test 14 7.71 108.00 
Control 16 22.31 357.00 
Total 30 
  
24 hrs shoulder 
Test 14 8.96 125.50 
Control 16 21.22 339.50 
Total 30 
  
Hospitalisation 
duration in days 
Test 14 9.79 137.00 
Control 16 20.50 328.00 
Total 30 
  
a. Operating time in minutes = > 120 
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Group Statisticsa 
Groups N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Upper abdomen 
Pain 
Test 14 1.57 .852 .228 
Control 16 2.00 .632 .158 
8 hr Shoulder 
Test 14 1.29 .994 .266 
Control 16 5.19 1.601 .400 
12 hrs shoulder 
Test 14 1.07 .917 .245 
Control 16 4.50 1.506 .376 
24 hrs shoulder 
Test 14 .57 .938 .251 
Control 16 2.50 1.095 .274 
Hospitalisation 
duration in days 
Test 14 1.8 .893 .239 
Control 16 3.1 .806 .202 
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STATISTICS IN PATIENTS WITH OPERATING TIME >120 min  
Test Statisticsa,b 
 
Mann-Whitney U Z 
Asymp. Sig.  
(2-tailed) 
Upper abdomen 
Pain 
78.000 -1.538 .124 
8 hr Shoulder 1.000 -4.659 .0005 
12 hrs shoulder 3.000 -4.619 .0005 
24 hrs shoulder 20.500 -3.924 .0005 
Hospitalisation 
duration in days 
32.000 -3.447 .001 
a. Operating time in minutes = > 120 
b. Grouping Variable: Groups 
 
 
 
8 hrs 12 hrs 24 hrs 
Test 1.29 1.07 .57 
Control 5.19 4.50 2.50 
 
 
 
 
The upper abdomen pain score at 8 hours in 
the test group was 1.57+/
operating time >120 min in the control group was 2.0 +/
0.124 (>0.05). Hence the variation in abdomen pain scores is not signific
 
0.00
0.50
1.00
1.50
2.00
2.50
Abdomen Pain in Operating time > 120 min
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operating time >120 min in 
- 0.852 and the upper abdomen pain score at 8 hrs in 
- 0.632. The p value = 
 
1.57
2.00
Test Control
 
ant. 
  
 
The shoulder pain score at 8 hours in operating time >120 min in the test 
group was 1.29+/- 0.994and the shoulder pain score at 8 hrs in operating time 
>120 minin the control group was 5.19 +/
(<0.05). Hence the var
pain is more in the control group.
 
 
 
 
1.29
0.00
1.00
2.00
3.00
4.00
5.00
6.00
8 hrs
Shoulder pain in Operating time > 120 min
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- 1.601. The p value = 0.0005 
iation in shoulder pain scores at 8 hrs is significant. The 
 
1.07
.57
5.19
4.50
12 hrs
Test Control
 
2.50
24 hrs
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The shoulder pain score at 12 hours in operating time >120 min in the 
test group was 1.07 +/- 0.917 and the shoulder pain score at 12 hrs in operating 
time >120 min in the control group was 4.50 +/- 1.506. The p value = 0.0005 
(<0.05) . Hence the variation in shoulder pain scores at 12 hrs is significant. 
The pain is more in the control group. 
The shoulder pain score at 24 hours in operating time >120 min in the 
test group was 0.57 +/- 0.938 and the shoulder pain score at 24 hrs in operating 
time >120 min in the control group was 2.50 +/- 1.095. The p value = 0.0005 
(<0.05) . Hence the variation in shoulder pain scores at 24 hrs is significant. 
The pain is more in the control group. 
  
  
 
 
 
          The mean hospitalisation durationin operating time >120 min  in Group I 
Test was 1.8 +/- 0.893 days. The mean hospitalisation duration in operating 
time >120 min in Group II Control was 3.1 +/
(<0.05).  The difference is hospitalisation duration between the 2 groups is 
significant. Hospitalisation duration is more in the control group.
 
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Hospital stay in Operating time > 120 
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- 0.806 days. The p
 
1.8
3.1
Test Control
min
 value = 0.001 
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SUMMARY OF RESULTS 
• The test and control patients were matched in age, sex and duration 
of surgery. 
UPPER ABDOMEN PAIN SCORES 
• The upper abdomen pain score at 8 hours in the test group was 1.2 +/- 
0.756 and the upper abdomen pain score at 8 hrs in the control group 
was 1.4 +/- 0.904. The p value = 0.225 (>0.05) . Hence the variation in 
abdomen pain scores are not significant. 
• The upper abdomen pain score at 8 hours in operating time >120 min in 
the test group was 1.57 +/- 0.852 and the upper abdomen pain score at 8 
hrs in operating time >120 min in the control group was 2.0 +/- 0.632. 
The p value = 0.124 (>0.05). Hence the variation in abdomen pain 
scores is not significant. 
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SHOULDER PAIN SCORES 
• The shoulder pain score at 8 hours in the test group was 1.02 +/- 1.237 
and the shoulder pain score at 8 hrs in the control group was 3.08 +/- 
2.602. The p value = 0.0005 (<0.05) . Hence the variation in shoulder 
pain scores at 8 hrs is significant. The pain is more in the control group 
• The shoulder pain score at 12 hours in the test group was 0.92 +/- 1.307 
and the shoulder pain score at 8 hrs in the control group was 2.56 +/- 
2.426. The p value = 0.001 (<0.05) . Hence the variation in shoulder 
pain scores at 12 hrs is significant. The pain is more in the control group 
• The shoulder pain score at 24 hours in the test group was 0.44 +/- 0.812 
and the shoulder pain score at 8 hrs in the control group was 1.38 +/- 
1.369. The p value = 0.0005 (<0.05) . Hence the variation in shoulder 
pain scores at 24 hrs is significant. The pain is more in the control group 
• The shoulder pain score at 8 hours in operating time >120 min in the test 
group was 1.29 +/- 0.994 and the shoulder pain score at 8 hrs in 
operating time >120 min in the control group was 5.19 +/- 1.601. The p 
value = 0.0005 (<0.05) . Hence the variation in shoulder pain scores at 8 
hrs is significant. The pain is more in the control group. 
• The shoulder pain score at 12 hours in operating time >120 min in the 
test group was 1.07 +/- 0.917 and the shoulder pain score at 12 hrs in 
operating time >120 min in the control group was 4.50 +/- 1.506. The p 
value = 0.0005 (<0.05) . Hence the variation in shoulder pain scores at 
12 hrs is significant. The pain is more in the control group. 
71 
 
• The shoulder pain score at 24 hours in operating time >120 min in the 
test group was 0.57 +/- 0.938 and the shoulder pain score at 24 hrs in 
operating time >120 min in the control group was 2.50 +/- 1.095. The p 
value = 0.0005 (<0.05) . Hence the variation in shoulder pain scores at 
24 hrs is significant. The pain is more in the control group 
 
HOSPITALISATION DURATION 
• The mean hospitalisation duration in Group I Test was 1.72 +/- 0.970 
days. The mean hospitalisation duration in Group II Control was 2.20 
+/- 1.229 days. The p value = 0.054 (>0.05).  The difference is 
hospitalisation duration between the 2 groups is not significant. 
• The mean hospitalisationdurationin operating time >120 min  in Group I 
Test was 1.8 +/- 0.893 days. The mean hospitalisation duration in 
operating time >120 min in Group II Control was 3.1 +/- 0.806 days. 
The p value = 0.001 (<0.05).  The difference is hospitalisation duration 
between the 2 groups is significant. Hospitalisation duration is more in 
the control group. 
 
 
 
 
  
 
 
CONCLUSION 
  
72 
 
 
 
CONCLUSION OF RESULTS 
Active gas aspiration did not produce any significant reduction in upper 
abdomen pain scores. However active gas aspiration produced significant pain 
reduction in shoulder pain scores at 8, 12 and 24 hrs.There was no difference in 
hospitalisation duration due to active gas aspiration at the end of Laparoscopic 
Cholecystectomy. 
In patients whose operating duration times exceeded 120 minutes, active 
gas aspiration did not produce any significant reduction in upper abdomen pain 
scores. In patients whose operating duration times exceeded 120 minutes, 
significant pain reduction in shoulder pain scores at 8, 12 and 24 hrs. 
Moreover, significant reduction hospitalisation duration was seen in the group 
which underwent active gas aspiration at the end of Laparoscopic 
Cholecystectomy. 
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DISCUSSION 
Laparoscopic Cholecystectomy is one of the most common general 
surgical procedures performed worldwide. Surgeons all over the world have 
strived to improve their technique and provide better outcomes to their patients. 
Pain is a major part of the post-operative recovery process.  Better pain 
management results in increased patient satisfaction and early return to normal 
activities. Effective pain management also leads to reduced hospitalisation 
duration thereby decreasing costs for the healthcare providers. In a country like 
India where majority of the healthcare needs are met by the public healthcare 
system, reduced healthcare costs will mean that the funds can be allocated 
towards more pressing needs.  
In our study we had analysed the effect of active sub-diaphragmatic gas 
aspiration on upper abdomen and shoulder pain scores. There were a few 
studies which had done some research on this topic. We performed the study in 
a public health setting. Our study validated the previous research. Our study 
concluded that active gas aspiration did not produce any significant reduction 
in upper abdomen pain scores. However active gas aspiration produced 
significant pain reduction in shoulder pain scores at 8, 12 and 24 hrs. There was 
no difference in hospitalisation duration due to active gas aspiration at the end 
of Laparoscopic Cholecystectomy. 
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In patients whose operating duration times exceeded 120 minutes,active 
gas aspiration did not produce any significant reduction in upper abdomen pain 
scores. In patients whose operating duration times exceeded 120 minutes, 
significant pain reduction in shoulder pain scores at 8, 12 and 24 hrs. 
Moreover, significant reduction hospitalisation duration was seen in the group 
which underwent active gas aspiration at the end of Laparoscopic 
Cholecystectomy. 
We believe that the residual effects of CO2 are responsible for the 
diaphragmatic pain in post LC patients. Therefore active gas aspiration can be 
adapted as a standard practice at the end of surgery. 
 
SCOPE OF IMPROVEMENT 
There is however a scope for improvement in the study. Measuring the 
total insufflated volume and continuous pressure monitoring with an intra-
abdominal probe placed in the sub-diaphragmatic region would be a very 
accurate means of measuring the sub-diaphragmatic pressure. The study can 
also be performed in a setting of low pressure pneumo-peritoneum.  
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CONCLUSION 
 
Active gas aspiration is an effective and simple means  of  reducing the 
CO2 gas in the sub-diaphragmatic space. It does not involve any extra cost. 
There is significant reduction in shoulder pain scores when active gas 
aspiration is performed. We advocate active gas aspiration at the end of 
Laparoscopic Cholecystectomy be adopted as a standard practice all over the 
world. 
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INFORMATION SHEET 
• TITLE: “A STUDY ON ACTIVE GAS ASPIRATION TO 
REDUCE PAIN AFTER LAPAROSCOPIC 
CHOLECYSTECTOMY” 
Name of Investigator: Dr.VINAYAK S RENGAN   
Name of Participant: 
Purpose of Research: To evaluate the effect of active gas aspiration in patients 
undergoing Laparoscopic Cholecystectomy on  shoulder pain and upper 
abdominal pain. 
Study Design: Randomised Control Trial 
Blinding: Single blinded ( Patient ) 
Study Procedures:  
One group of patients will be subjected to active gas aspiration with a suction 
cannula for 5 min at the end of Laparoscopic Cholecystectomy.  
Other group of patients will be subjected to a standard Laparoscopic 
Cholecystectomy after routine investigations. Proper consent from both 
groups will be obtained 
Possible Risks: No proven risks to the patient 
Possible benefits:  
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To patient : A better understanding of diaphragmatic and shoulder pain post 
cholecystectomy which can lead to a more comfortable post-operative period 
for the patient. 
To doctor & to other people:  The study will help the surgeon gain a better 
understanding of the principle of active gas aspiration and its possible benefits 
in providing a better post-operative experience to the patient 
Confidentiality of the information obtained from you: The privacy of the 
patients in the research will be maintained throughout the study. In the event of 
any publication or presentation resulting from the research, no personally 
identifiable information will be shared 
Can you decide to stop participating in the study: Taking part in this study 
is voluntary. You are free to decide whether to participate in this study or to 
withdraw at any time 
How will your decision to not participate in the study affect you: Your 
decision will not result in any loss of benefits to which you are otherwise 
entitled. 
 
Signature of Investigator         Signature of Participant 
Date : 
Place : 
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PATIENT CONSENT FORM 
 
 
 
 
 
 
 
I confirm that I have understood the purpose of procedure for the above study. I have the opportunity 
to ask question and all my questions and doubts have been answered to my complete satisfaction. ❏ 
I understand that my participation in the study is voluntary and that I am free to withdraw at any time 
without giving reason, without my legal rights being affected. ❏ 
I understand that sponsor of the clinical study, others working on the sponsor’s behalf, the Ethics 
committee and the regulatory authorities will not need my permission to look at my health 
records, both in respect of current study and any further research that may be conducted in 
relation to it, even if I withdraw from the study I agree to this access. However, I understand that 
my identity will not be revealed in any information released to third parties or published, unless 
as required under the law. I agree not to restrict the use of any data or results that arise from this 
study. ❏ 
I agree to take part in the above study and to comply with the instructions given during the study and 
faithfully cooperate with the study team and to immediately inform the study staff if I suffer from 
any deterioration in my health or well being or any unexpected or unusual symptoms. ❏ 
I hereby consent to participate in this study 
 
❏ 
I hereby give permission to undergo complete clinical examination and diagnostic tests including 
hematological, biochemical, radiological tests and to undergo treatment ❏ 
Signature/thumb impression 
Patient’s Name and Address 
 
 
Study Detail : “A STUDY ON ACTIVE GAS ASPIRATION TO REDUCE PAIN
AFTER LAPAROSCOPIC CHOLECYSTECTOMY” 
 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name :  
Patient’s Age :  
In Patient Number :  
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